{"story":{"id":1815190,"title":"Foundayo approval a welcome addition to GLP-1 treatment options - Diabetes Australia","permalink":"https://checknews.org/historia.php?id=1815190","status":"quiet","category":"general","country":"AU","country_name":"Australia","language":"en","first_seen_at":"2026-11-17T18:43:35-06:00","last_activity_at":"2026-11-17T18:43:35-06:00","source_count":1,"article_count":1,"image":"https://www.diabetesaustralia.com.au/wp-content/uploads/Diabetes-Australia_logo_colour_1000x562.jpg","articles":[{"title":"Foundayo approval a welcome addition to GLP-1 treatment options - Diabetes Australia","publisher":"Diabetes Australia","url":"https://www.diabetesaustralia.com.au/mediarelease/foundayo-approval-a-welcome-addition-to-glp-1-treatment-options/","country":"AU","country_name":"Australia","language":"en","published_at":"2026-11-17T18:43:35-06:00"}],"source_url":"https://www.diabetesaustralia.com.au/mediarelease/foundayo-approval-a-welcome-addition-to-glp-1-treatment-options/","publishers":[{"name":"Diabetes Australia","country":"AU","country_name":"Australia"}],"countries":["AU"]},"generated_at":"2026-11-22T02:34:57-06:00"}